Physician Expert Panels

Cepmed’s Canada-wide physician survey showed that most physicians lack sufficient formal training in personalized medicine, that they report an absence of clinical practice guidelines, and that they are actively seeking information on personalized genetic testing to facilitate treatment decision-making. Therefore, a key initiative of Cepmed has been to form physician expert panels to develop recommendations for the advancement of personalized medicine and strategies for its education and adoption.

These panels in oncology, cardiology, and family medicine (the Strategic Advisory Panel) will review available validated tests and practice guidelines in each area and make recommendations for incorporating personalized medicine tests or following existing guidelines using a personalized approach. Based on these recommendations future initiatives will be directed to working with the relevant healthcare and medical organizations to develop and adopt clinical practice guidelines that incorporate personalized medicine tests.

These efforts will ensure that personalized medicine is incorporated into everyday medical practice, as quickly as possible, resulting in improved health care in Canada. Cepmed’s goal is to network physicians across Canada who have an interest in the advancement of personalized medicine. We invite physicians and healthcare workers to contact us and lend their voice and experience in supporting this goal.

Oncology Expert Panel

Chairperson: Dr. Charles Butts

Members: Dr. Gerry Batist, Dr. Malcolm Moore, Dr. Charles Blanke, Dr. Suzanne Kamel-Reid, Dr. Michael Sawyer

Mandate: This panel is working toward developing clinical practice guidelines for personalized medicine in oncology, where evidence provides clear direction for improving quality of care. The work of this panel should:

  • Describe appropriate use of personalized medicine based on the best available scientific evidence and broad consensus;
  • Reduce inappropriate variation in practice;
  • Provide a more rational basis for referral;
  • Provide a focus for continuing education;
  • Promote efficient use of resources; and
  • Highlight shortcomings of existing literature and suggest appropriate future research.

The panel’s findings will be submitted for peer reviewed publication.

Cardiovascular Expert Panel

Chairperson: Dr. Jean-Claude Tardif

Members: Dr. Andrew Krahn, Dr. Bob Roberts, Dr. Paul Khairy, Dr. Candace Lee, Dr. Gregor Andelfinger, Dr. Milan Gupta

Mandate: This panel is working toward developing clinical practice guidelines for personalized medicine in cardiovascular medicine, where evidence provides clear direction for improving quality of care. The work of this panel should:

  • Describe appropriate use of personalized medicine based on the best available scientific evidence and broad consensus;
  • Reduce inappropriate variation in practice;
  • Provide a more rational basis for referral;
  • Provide a focus for continuing education;
  • Promote efficient use of resources; and
  • Highlight shortcomings of existing literature and suggest appropriate future research.

The panel’s findings will be submitted for peer reviewed publication.

Strategic Advisory Panel

Chairperson: Dr. Simon Sutcliffe

Members: Dr. Sean Blaine, Dr. David Keast, Dr. Mark Elwood, Dr. Jeffrey Hoch, Jill Davies, Dr. Serge Dulude

Mandate: This panel, made up of experts in the field of personalized medicine as well as leaders in family medicine, will develop strategies for promoting the uptake and education of personalized medicine among family physicians, where evidence provides clear direction for improving quality of care. The work of this panel should:

  • Develop a communications plan for primary care physician engagement;
  • Develop a communications plan for public engagement;
  • Develop an approach and implementation plan for continuing professional education;
  • Document leading practices, shortcomings, and potential areas of improvement for the future;
  • Research/investigation of existing knowledge for primary care physicians; and
  • Develop recommendations for the effective use of resources/funding options in personalized medicine.

           The panel’s findings will be submitted for peer reviewed publication.